US5552155A
(en)
*
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
US5776486A
(en)
|
1993-05-28 |
1998-07-07 |
Aphios Corporation |
Methods and apparatus for making liposomes containing hydrophobic drugs
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
NZ313264A
(en)
|
1995-08-01 |
1999-11-29 |
Novartis Ag |
Liposomal oligonucleotide compositions
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
US7262173B2
(en)
|
1997-03-21 |
2007-08-28 |
Georgetown University |
Chemosensitizing with liposomes containing oligonucleotides
|
WO1998051278A2
(en)
|
1997-05-14 |
1998-11-19 |
Inex Pharmaceuticals Corporation |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
AU8428998A
(en)
|
1997-07-24 |
1999-02-16 |
Inex Pharmaceuticals Corporation |
Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
AU1830200A
(en)
|
1998-11-25 |
2000-06-13 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
AU5905400A
(en)
|
1999-07-14 |
2001-02-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions for delivery and retention of active agents to lymph nodes
|
US7094423B1
(en)
|
1999-07-15 |
2006-08-22 |
Inex Pharmaceuticals Corp. |
Methods for preparation of lipid-encapsulated therapeutic agents
|
CN1284523C
(zh)
|
2000-10-04 |
2006-11-15 |
协和发酵工业株式会社 |
由脂质膜被覆微粒的方法
|
US7713942B2
(en)
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
US20030077829A1
(en)
|
2001-04-30 |
2003-04-24 |
Protiva Biotherapeutics Inc.. |
Lipid-based formulations
|
US7364750B2
(en)
|
2001-04-30 |
2008-04-29 |
The University Of British Columbia |
Autogene nucleic acids encoding a secretable RNA polymerase
|
AU2002340662B2
(en)
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
JP4722481B2
(ja)
|
2002-06-28 |
2011-07-13 |
プロティバ バイオセラピューティクス リミテッド |
リポソーム製造方法および装置
|
AU2004257373B2
(en)
|
2003-07-16 |
2011-03-24 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
JP4842821B2
(ja)
*
|
2003-09-15 |
2011-12-21 |
プロチバ バイオセラピューティクス インコーポレイティッド |
ポリエチレングリコール修飾脂質化合物およびその使用
|
CN101031287A
(zh)
|
2004-03-02 |
2007-09-05 |
麻省理工学院 |
纳米细胞药物递送系统
|
JP4796062B2
(ja)
|
2004-06-07 |
2011-10-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
脂質封入干渉rna
|
EP1781593B1
(en)
|
2004-06-07 |
2011-12-14 |
Protiva Biotherapeutics Inc. |
Cationic lipids and methods of use
|
EP1773857A4
(en)
|
2004-07-02 |
2009-05-13 |
Protiva Biotherapeutics Inc |
THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
|
US20060051405A1
(en)
|
2004-07-19 |
2006-03-09 |
Protiva Biotherapeutics, Inc. |
Compositions for the delivery of therapeutic agents and uses thereof
|
US20060134189A1
(en)
|
2004-11-17 |
2006-06-22 |
Protiva Biotherapeutics, Inc |
siRNA silencing of apolipoprotein B
|
AU2006236453B2
(en)
|
2005-01-25 |
2012-02-23 |
Board Of Regents, The University Of Texas System |
Delivery of siRNA by neutral lipid compositions
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
US20080088046A1
(en)
|
2006-10-13 |
2008-04-17 |
Steffen Panzner |
Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
|
US20070087045A1
(en)
|
2005-10-14 |
2007-04-19 |
Industrial Technology Research Institute |
Lipid carrier and method of preparing the same
|
WO2007048046A2
(en)
|
2005-10-20 |
2007-04-26 |
Protiva Biotherapeutics, Inc. |
Sirna silencing of filovirus gene expression
|
EP2395012B8
(en)
|
2005-11-02 |
2018-06-06 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
US20070218122A1
(en)
|
2005-11-18 |
2007-09-20 |
Protiva Biotherapeutics, Inc. |
siRNA silencing of influenza virus gene expression
|
US8598333B2
(en)
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
CA2660204A1
(en)
|
2006-08-16 |
2008-02-21 |
Protiva Biotherapeutics, Inc. |
Nucleic acid modulation of toll-like receptor-mediated immune stimulation
|
PT2081551E
(pt)
*
|
2006-10-06 |
2013-02-18 |
Scil Technology Gmbh |
Formação de vesículas secas reconstituídas para aplicação farmacêutica
|
US20100297242A1
(en)
|
2007-10-17 |
2010-11-25 |
Tae-Gwan Park |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
CA2710713C
(en)
|
2007-12-27 |
2017-09-19 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
NZ588583A
(en)
|
2008-04-15 |
2012-08-31 |
Protiva Biotherapeutics Inc |
Novel lipid formulations for nucleic acid delivery
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
JP2011529912A
(ja)
|
2008-07-31 |
2011-12-15 |
エンゾン ファーマシューティカルズ,インコーポレーテッド |
核酸送達システム用のナノ粒子組成物
|
WO2010042877A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
EA029762B1
(ru)
|
2008-10-20 |
2018-05-31 |
Элнилэм Фармасьютикалз, Инк. |
Композиции и способы для ингибирования экспрессии транстиретина
|
KR20220150995A
(ko)
|
2008-11-10 |
2022-11-11 |
알닐람 파마슈티칼스 인코포레이티드 |
치료제 운반용 신규 지질 및 조성물
|
US20110305769A1
(en)
|
2008-11-17 |
2011-12-15 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
TW201021853A
(en)
|
2008-11-17 |
2010-06-16 |
Enzon Pharmaceuticals Inc |
Releasable cationic lipids for nucleic acids delivery systems
|
US10292932B2
(en)
|
2008-12-26 |
2019-05-21 |
Samyang Biopharmaceuticals Corporation |
Polymeric micelle particle comprising anionic drugs and method of preparing the same
|
RU2011142620A
(ru)
|
2009-03-25 |
2013-04-27 |
Новартис Аг |
ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЛЕКАРСТВЕННОЕ СРЕДСТВО И киРНК
|
SG10201402054UA
(en)
|
2009-05-05 |
2014-09-26 |
Muthiah Manoharan |
Lipid compositions
|
CN104873464B
(zh)
|
2009-06-10 |
2018-06-22 |
阿布特斯生物制药公司 |
改进的脂质制剂
|
US8283333B2
(en)
|
2009-07-01 |
2012-10-09 |
Protiva Biotherapeutics, Inc. |
Lipid formulations for nucleic acid delivery
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
AP2015008874A0
(en)
*
|
2009-08-14 |
2015-11-30 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
KR102279458B1
(ko)
|
2009-09-11 |
2021-07-21 |
아이오니스 파마수티컬즈, 인코포레이티드 |
헌팅틴 발현의 조절
|
CN107028886A
(zh)
|
2009-11-04 |
2017-08-11 |
不列颠哥伦比亚大学 |
含有核酸的脂质粒子及相关的方法
|
PT2506857T
(pt)
|
2009-12-01 |
2018-05-14 |
Translate Bio Inc |
Entrega de arnm para o acréscimo de proteínas e enzimas em doenças genéticas humanas
|
CN102892406B
(zh)
|
2010-01-19 |
2015-04-08 |
波利皮得有限公司 |
缓释核酸基质组合物
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
KR101198715B1
(ko)
|
2010-05-14 |
2012-11-13 |
한국생명공학연구원 |
핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
|
US20100239521A1
(en)
*
|
2010-06-01 |
2010-09-23 |
Mohammad Reza Mozafari |
Method for the preparation of micro- and nano-sized carrier systems for the encapsulation of bioactive substances
|
US9012498B2
(en)
|
2010-06-03 |
2015-04-21 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
DK4066819T3
(da)
|
2010-08-31 |
2023-04-24 |
Glaxosmithkline Biologicals Sa |
Små liposomer til levering af RNA, der koder for immunogen
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
SI2717893T1
(sl)
*
|
2011-06-08 |
2019-10-30 |
Translate Bio Inc |
Sestavki lipidnih nanodelcev in postopki za dostavo mRNA
|
EP4074693A1
(en)
|
2011-06-08 |
2022-10-19 |
Translate Bio, Inc. |
Cleavable lipids
|
US9011903B2
(en)
|
2011-06-08 |
2015-04-21 |
Nitto Denko Corporation |
Cationic lipids for therapeutic agent delivery formulations
|
CN103619325A
(zh)
|
2011-07-04 |
2014-03-05 |
国立血清研究所 |
用于生产脂质体的方法
|
EP3508220A1
(en)
|
2011-08-31 |
2019-07-10 |
GlaxoSmithKline Biologicals S.A. |
Pegylated liposomes for delivery of immunogen-encoding rna
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
AU2012318249B2
(en)
|
2011-10-05 |
2016-04-21 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing aldehyde dehydrogenase
|
CA2853685C
(en)
|
2011-11-04 |
2019-09-03 |
Nitto Denko Corporation |
Single use system for sterilely producing lipid-nucleic acid particles
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
RS63244B1
(sr)
|
2011-12-16 |
2022-06-30 |
Modernatx Inc |
Kompozicije modifikovane mrna
|
KR102239887B1
(ko)
|
2012-02-24 |
2021-04-13 |
아뷰터스 바이오파마 코포레이션 |
트리알킬 양이온성 지질 및 그의 사용 방법
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
JP6283655B2
(ja)
|
2012-03-29 |
2018-02-21 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
イオン化可能なカチオン性脂質
|
US20160289674A1
(en)
|
2012-04-02 |
2016-10-06 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
EP2833892A4
(en)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
JP6561378B2
(ja)
|
2012-06-08 |
2019-08-21 |
トランスレイト バイオ, インコーポレイテッド |
非肺標的細胞へのmRNAの経肺送達
|
HRP20211424T2
(hr)
|
2012-06-08 |
2022-02-18 |
Nitto Denko Corporation |
Lipidi za formulacije namijenjene unosu terapijskog sredstva
|
AU2014239184B2
(en)
|
2013-03-14 |
2018-11-08 |
Translate Bio, Inc. |
Methods and compositions for delivering mRNA coded antibodies
|
WO2014152513A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS
|
EP2971013B1
(en)
*
|
2013-03-15 |
2020-08-19 |
The University Of British Columbia |
Lipid nanoparticles for transfection and related methods
|
EP2972360B1
(en)
|
2013-03-15 |
2018-03-07 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
KR102109188B1
(ko)
|
2013-04-01 |
2020-05-11 |
삼성전자주식회사 |
양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도
|
EP3019595A4
(en)
*
|
2013-07-09 |
2016-11-30 |
|
THERAPEUTIC USES OF A GENERIC CHANGE WITH CRISPR / CAS SYSTEMS
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
WO2015021465A2
(en)
|
2013-08-09 |
2015-02-12 |
New York University |
Protein engineered systems for delivery of molecules
|
CN105658242A
(zh)
|
2013-10-22 |
2016-06-08 |
夏尔人类遗传性治疗公司 |
用于苯丙酮尿症的mrna疗法
|
EA201690588A1
(ru)
|
2013-10-22 |
2016-09-30 |
Шир Хьюман Дженетик Терапис, Инк. |
Доставка мрнк в цнс и ее применение
|
CA2928078A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger rna
|
AU2014340092B2
(en)
|
2013-10-22 |
2019-09-19 |
Translate Bio, Inc. |
mRNA therapy for Argininosuccinate Synthetase Deficiency
|
AU2015208837B2
(en)
|
2014-01-21 |
2020-06-18 |
Anjarium Biosciences Ag |
Hybridosomes, compositions comprising the same, processes for their production and uses thereof
|
ES2745769T3
(es)
|
2014-03-10 |
2020-03-03 |
Editas Medicine Inc |
Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10)
|
EP3450553B1
(en)
|
2014-03-24 |
2019-12-25 |
Translate Bio, Inc. |
Mrna therapy for treatment of ocular diseases
|
WO2015154002A1
(en)
|
2014-04-04 |
2015-10-08 |
Ohio State Innovation Foundation |
Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
|
SG11201608798YA
(en)
*
|
2014-04-23 |
2016-11-29 |
Modernatx Inc |
Nucleic acid vaccines
|
JP6557722B2
(ja)
|
2014-05-30 |
2019-08-07 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
核酸の送達のための生分解性脂質
|
EP3155116A4
(en)
|
2014-06-10 |
2017-12-27 |
Massachusetts Institute Of Technology |
Method for gene editing
|
CN111588695A
(zh)
|
2014-06-24 |
2020-08-28 |
川斯勒佰尔公司 |
用于递送核酸的立体化学富集组合物
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
CN114146063A
(zh)
|
2014-07-02 |
2022-03-08 |
川斯勒佰尔公司 |
信使rna的包封
|
MA56412A
(fr)
|
2014-12-05 |
2022-05-04 |
Translate Bio Inc |
Thérapie par l'arn messager pour le traitement des maladies articulaires
|
WO2016118697A1
(en)
*
|
2015-01-21 |
2016-07-28 |
Phaserx, Inc. |
Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
|
WO2016118725A1
(en)
|
2015-01-23 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
EP3900702A1
(en)
|
2015-03-19 |
2021-10-27 |
Translate Bio, Inc. |
Mrna therapy for pompe disease
|
WO2016189532A1
(en)
|
2015-05-26 |
2016-12-01 |
Ramot At Tel-Aviv University Ltd. |
Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes
|
EP3319976B1
(en)
|
2015-07-09 |
2021-09-01 |
Insmed Incorporated |
Compositions and methods for treating lung diseases and lung injury
|
AU2016324310B2
(en)
|
2015-09-17 |
2021-04-08 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
CA3002922A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
ANTICANCER VACCINES
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
EP3368089A4
(en)
|
2015-10-26 |
2019-05-29 |
Translate Bio Ma, Inc. |
NANOPARTICLE FORMULATIONS FOR ADMINISTRATION OF NUCLEIC ACID COMPLEXES
|
WO2017099823A1
(en)
|
2015-12-10 |
2017-06-15 |
Modernatx, Inc. |
Compositions and methods for delivery of therapeutic agents
|
ES2901102T3
(es)
|
2015-12-18 |
2022-03-21 |
Samyang Holdings Corp |
Método para preparar una micela polimérica que contiene fármaco aniónico
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
CN107281103A
(zh)
|
2016-04-11 |
2017-10-24 |
百奥迈科生物技术有限公司 |
具有高含量阳性脂质化合物的脂质体制剂及其应用
|
WO2017201258A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
WO2017201332A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding acyl-coa dehydrogenase, very long-chain for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
CN109312313A
(zh)
|
2016-06-13 |
2019-02-05 |
川斯勒佰尔公司 |
用于治疗鸟氨酸转氨甲酰酶缺乏症的信使rna疗法
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
WO2018064755A1
(en)
|
2016-10-03 |
2018-04-12 |
Precision Nanosystems Inc. |
Compositions for transfecting resistant cell types
|
WO2018075980A1
(en)
|
2016-10-21 |
2018-04-26 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
SG11201903460QA
(en)
|
2016-10-26 |
2019-05-30 |
Curevac Ag |
Lipid nanoparticle mrna vaccines
|
DK3538515T3
(da)
|
2016-11-08 |
2022-10-17 |
Univ Ramot |
Kationiske lipider til nukleinsyreafgivelse og fremstilling deraf
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
US20180153822A1
(en)
|
2016-11-10 |
2018-06-07 |
Translate Bio, Inc. |
Process of Preparing mRNA-Loaded Lipid Nanoparticles
|
CN110114058B
(zh)
|
2016-11-10 |
2023-05-26 |
川斯勒佰尔公司 |
用于递送mrna的改进的基于ice的脂质纳米颗粒制剂
|
US20180185516A1
(en)
|
2016-12-09 |
2018-07-05 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
US10383952B2
(en)
|
2016-12-21 |
2019-08-20 |
Arcturus Therapeutics, Inc. |
Ionizable cationic lipid for RNA delivery
|
AU2018234692B2
(en)
|
2017-03-15 |
2022-06-02 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US20200181623A1
(en)
*
|
2017-05-18 |
2020-06-11 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
WO2018220553A1
(en)
|
2017-05-30 |
2018-12-06 |
Glaxosmithkline Biologicals Sa |
Methods for manufacturing a liposome encapsulated rna
|
US20200131498A1
(en)
|
2017-06-14 |
2020-04-30 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
EP3638215A4
(en)
|
2017-06-15 |
2021-03-24 |
Modernatx, Inc. |
RNA FORMULATIONS
|
EP3641834B1
(en)
|
2017-06-19 |
2023-10-04 |
Translate Bio, Inc. |
Messenger rna therapy for the treatment of friedreich's ataxia
|
MX2020000495A
(es)
|
2017-07-14 |
2020-08-20 |
Oncorus Inc |
Polinucleotidos encapsulados y metodos de uso.
|
WO2019027055A1
(ja)
|
2017-08-04 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸含有脂質ナノ粒子
|
US11639329B2
(en)
|
2017-08-16 |
2023-05-02 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
CA3073018A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
US11542225B2
(en)
|
2017-08-17 |
2023-01-03 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
US20200353062A1
(en)
|
2017-11-09 |
2020-11-12 |
Immunovaccine Technologies Inc. |
Pharmaceutical compositions, methods for preparation comprising sizing of lipid vesicle particles, and uses thereof
|
EP3720422A4
(en)
|
2017-12-06 |
2021-08-25 |
NewSouth Innovations Pty Limited |
LIPOSOMAL SYSTEM FOR DRUG DELIVERY
|
WO2019118621A1
(en)
|
2017-12-12 |
2019-06-20 |
The Johns Hopkins University |
Methods for making giant vesicles and their use
|
MA51306A
(fr)
|
2017-12-20 |
2020-10-28 |
Translate Bio Inc |
Compositions et procédés améliorés pour le traitement du déficit en ornithine transcarbamylase
|
US20210024928A1
(en)
|
2018-02-16 |
2021-01-28 |
Mina Therapeutics Limited |
C/ebp alpha sarna compositions and methods of use
|
US20210002640A1
(en)
|
2018-02-28 |
2021-01-07 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
CA3095125A1
(en)
|
2018-03-27 |
2019-10-03 |
Factor Bioscience Inc. |
Nucleic acid-based therapeutics
|
WO2019191780A1
(en)
|
2018-03-30 |
2019-10-03 |
Arcturus Therapeutics, Inc. |
Lipid particles for nucleic acid delivery
|
US20210170017A1
(en)
|
2018-04-17 |
2021-06-10 |
Curevac Ag |
Novel rsv rna molecules and compositions for vaccination
|
WO2019210394A1
(en)
|
2018-04-29 |
2019-11-07 |
Precision Nanosystems Inc. |
Compositions for transfecting resistant cell types
|
EP3787996A4
(en)
|
2018-05-01 |
2022-07-27 |
Fred Hutchinson Cancer Research Center |
NANOPARTICLES FOR GENE EXPRESSION AND THEIR USES
|
US20210189397A1
(en)
|
2018-05-10 |
2021-06-24 |
Northwestern University |
Self-manageable abnormal scar treatment with spherical nucleic acid (sna) technology
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
CN117430538A
(zh)
|
2018-05-24 |
2024-01-23 |
川斯勒佰尔公司 |
硫酯阳离子脂质
|
CA3106893A1
(en)
|
2018-07-21 |
2020-01-30 |
University Of Tennessee Research Foundation |
Neutral liposomes containing biologically active agents
|
EP3826608A1
(en)
|
2018-07-23 |
2021-06-02 |
Translate Bio, Inc. |
Dry power formulations for messenger rna
|
US20210315820A1
(en)
|
2018-07-30 |
2021-10-14 |
Trucode Gene Repair, Inc. |
Lipid nanoparticle formulations comprising nucleic acid mimics
|
JP2021535226A
(ja)
*
|
2018-09-04 |
2021-12-16 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
核酸を臓器特異的送達するための組成物および方法
|
WO2020051243A1
(en)
|
2018-09-04 |
2020-03-12 |
Ohio State Innovation Foundation |
Lipid nanoparticles and methods of using thereof
|
EP3849617A1
(en)
|
2018-09-14 |
2021-07-21 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
JP7410135B2
(ja)
|
2018-09-19 |
2024-01-09 |
モデルナティエックス インコーポレイテッド |
治療薬の細胞内送達のための化合物及び組成物
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
CN113166783A
(zh)
|
2018-10-09 |
2021-07-23 |
不列颠哥伦比亚大学 |
包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
|
MX2021005462A
(es)
|
2018-11-09 |
2021-08-24 |
Arbutus Biopharma Corp |
Lipidos cationicos que contienen silicio.
|
EP3876914A2
(en)
|
2018-11-09 |
2021-09-15 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
WO2020097379A2
(en)
|
2018-11-09 |
2020-05-14 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
WO2020097493A1
(en)
|
2018-11-09 |
2020-05-14 |
Arbutus Biopharma Corporation |
Negatively charged peg-lipid conjugates
|
JP2022506955A
(ja)
|
2018-11-09 |
2022-01-17 |
アルブータス・バイオファーマー・コーポレイション |
脂質ナノ粒子製剤
|
CA3119449A1
(en)
|
2018-11-12 |
2020-05-22 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
EP3880212B1
(en)
|
2018-11-16 |
2024-01-17 |
Nitto Denko Corporation |
Rna interference delivery formulation and methods for malignant tumors
|
EP3883592A1
(en)
|
2018-11-21 |
2021-09-29 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr
|
KR20210113260A
(ko)
|
2019-01-04 |
2021-09-15 |
온코루스, 인크. |
캡슐화된 rna 폴리뉴클레오타이드 및 사용 방법
|
EP3914236A4
(en)
|
2019-01-24 |
2022-10-26 |
Northwestern University |
HIGH-DENSITY LIPOPROTEINMIMETIC NANOPARTICLES USING LIPID-CONJUGATED CORE SCAFFOLDINGS
|
US20220023214A1
(en)
|
2019-01-24 |
2022-01-27 |
CannaClear Inc. |
Lecithin Vesicles for Oral Delivery
|
CN113767172A
(zh)
|
2019-01-31 |
2021-12-07 |
新南创新私人有限公司 |
脂质体纳米颗粒
|
CA3128215A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
CA3133858A1
(en)
|
2019-03-19 |
2020-09-24 |
Arcturus Therapeutics, Inc. |
Method of making lipid-encapsulated rna nanoparticles
|
JPWO2020189773A1
(ru)
|
2019-03-20 |
2020-09-24 |
|
|
CA3133394A1
(en)
|
2019-04-15 |
2020-10-22 |
Precision Nanosystems Inc. |
Nonviral modification of t cell gene expression
|
AU2020268798A1
(en)
|
2019-05-03 |
2021-11-04 |
Dicerna Pharmaceuticals, Inc. |
Double-stranded nucleic acid inhibitor molecules with shortened sense strands
|
CA3139321A1
(en)
|
2019-05-07 |
2020-11-12 |
Modernatx, Inc. |
Polynucleotides for disrupting immune cell activity and methods of use thereof
|
AU2020274758A1
(en)
|
2019-05-14 |
2021-12-23 |
Translate Bio, Inc. |
Improved process of preparing mRNA-loaded lipid nanoparticles
|
EP3982932A4
(en)
|
2019-06-14 |
2023-10-25 |
Particella, Inc. |
COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES
|
WO2020254535A1
(en)
|
2019-06-18 |
2020-12-24 |
Curevac Ag |
Rotavirus mrna vaccine
|
US20220396548A1
(en)
|
2019-06-20 |
2022-12-15 |
Precision NanoSystems ULC |
Ionizable lipids for nucleic acid delivery
|
KR20220042361A
(ko)
|
2019-06-29 |
2022-04-05 |
프레시젼 나노시스템스 인코퍼레이티드 |
핵산 전달을 위한 이온화 가능한 지질
|
BR112022001192A2
(pt)
|
2019-07-23 |
2022-03-15 |
Translate Bio Inc |
Composições estáveis de nanopartículas lipídicas carregadas com mrna e processos de produção
|
CA3145913A1
(en)
|
2019-07-29 |
2021-02-04 |
James Everett Dahlman |
Nanomaterials containing constrained lipids and uses thereof
|
JP2022543046A
(ja)
|
2019-07-30 |
2022-10-07 |
バーンダリ・インコーポレイテッド |
ウイルス様粒子ワクチン
|
JP2022543773A
(ja)
|
2019-07-31 |
2022-10-14 |
モデルナティエックス インコーポレイテッド |
免疫細胞へのrna干渉剤の送達のための組成物及び方法
|
CA3150061A1
(en)
|
2019-08-07 |
2021-02-11 |
Modernatx, Inc. |
Compositions and methods for enhanced delivery of agents
|
ES2918001A2
(es)
|
2019-08-14 |
2022-07-13 |
Acuitas Therapeutics Inc |
Nanoparticulas lipidicas mejoradas para el suministro de acidos nucleicos
|
MX2022001870A
(es)
|
2019-08-14 |
2022-05-30 |
Curevac Ag |
Combinaciones y composiciones de arn con propiedades inmunoestimuladoras disminuidas.
|
WO2021038508A1
(en)
|
2019-08-30 |
2021-03-04 |
Glaxosmithkline Biologicals Sa |
Jet mixing lipid nanoparticle manufacturing process
|
EP4031191A4
(en)
|
2019-09-18 |
2023-10-25 |
The Regents of the University of California |
PROTEIN-PRODUCING NANOLIPOSOMES AND THEIR USES
|
MX2022003269A
(es)
|
2019-09-19 |
2022-07-04 |
Modernatx Inc |
Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos.
|
IL292420A
(en)
|
2019-10-22 |
2022-06-01 |
Genevant Sciences Gmbh |
Ornithine transcarbamylase (otc) structures and methods for their use
|
EP4061797A1
(en)
|
2019-11-22 |
2022-09-28 |
Generation Bio Co. |
Ionizable lipids and nanoparticle compositions thereof
|
WO2021108731A1
(en)
|
2019-11-25 |
2021-06-03 |
The Methodist Hospital |
Aposome compositions and methods of use
|
EP3838266A1
(en)
|
2019-12-20 |
2021-06-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microfluidic production of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery
|
CN115135764A
(zh)
|
2019-12-31 |
2022-09-30 |
弗莱德哈钦森癌症中心 |
用于刺激和维持治疗部位处的免疫系统应答性的纳米颗粒系统
|
EP3858332A1
(en)
|
2020-01-31 |
2021-08-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bottom-up assembly of synthetic extracellular vesicles
|
TW202139976A
(zh)
|
2020-01-31 |
2021-11-01 |
美商現代公司 |
製備脂質奈米顆粒之方法
|
DE202021004130U1
(de)
|
2020-02-04 |
2022-10-26 |
Curevac Ag |
Coronavirus-Vakzine
|
CN113186203B
(zh)
|
2020-02-13 |
2022-12-30 |
斯微(上海)生物科技股份有限公司 |
治疗或者预防冠状病毒病的疫苗试剂
|
CN113999184A
(zh)
|
2020-02-28 |
2022-02-01 |
深圳深信生物科技有限公司 |
一种胺基脂质化合物、其制备方法和应用
|
EP4125821A2
(en)
|
2020-03-27 |
2023-02-08 |
Generation Bio Co. |
Novel lipids and nanoparticle compositions thereof
|
US11559577B2
(en)
|
2020-03-31 |
2023-01-24 |
Engimata, Inc. |
Immunogenic composition forming a vaccine, and a method for its manufacture
|
CN113456591B
(zh)
|
2020-03-31 |
2022-06-14 |
武汉合生科技有限公司 |
糖基聚醚类化合物脂质体及其制备方法和药物
|
WO2021207273A1
(en)
|
2020-04-07 |
2021-10-14 |
The Regents Of The University Of California |
Manufacturing of synthetic exosomes for cns and non-cns delivery of therapeutics
|
KR20230004563A
(ko)
|
2020-04-10 |
2023-01-06 |
노오쓰웨스턴 유니버시티 |
강력한 암 면역치료제로서 리포좀성 구형 핵산 내 캡슐화된 산화된 종양 세포 용해물
|
WO2021213924A1
(en)
|
2020-04-22 |
2021-10-28 |
BioNTech SE |
Coronavirus vaccine
|
EP4143217A2
(en)
|
2020-05-01 |
2023-03-08 |
Arcturus Therapeutics, Inc. |
Nucleic acids and methods of treatment for cystic fibrosis
|
WO2021226463A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
WO2021226468A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Improved compositions for cftr mrna therapy
|
CN115916158A
(zh)
|
2020-05-15 |
2023-04-04 |
翻译生物公司 |
用于mRNA递送的脂质纳米颗粒配制品
|
WO2021236479A2
(en)
|
2020-05-18 |
2021-11-25 |
Generation Bio Co. |
Novel lipids and nanoparticle compositions thereof
|
EP4153132A1
(en)
|
2020-05-18 |
2023-03-29 |
Max Biology Co. Ltd. |
Lipid-polymer compositions and methods of use
|
CA3179423A1
(en)
|
2020-05-19 |
2021-11-25 |
Robert Alexander WESSELHOEFT |
Circular rna compositions and methods
|
US20220049251A1
(en)
|
2020-05-20 |
2022-02-17 |
Nitto Denko Corporation |
dsRNA Directed to Coronavirus Proteins
|
MX2022015132A
(es)
|
2020-05-29 |
2023-03-08 |
CureVac SE |
Vacunas combinadas a base de acidos nucleicos.
|
CN115666722A
(zh)
|
2020-05-29 |
2023-01-31 |
昂克诺斯公司 |
包封的rna复制子和使用方法
|
US20230029453A1
(en)
|
2020-07-06 |
2023-02-02 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
US20230338288A1
(en)
|
2020-07-14 |
2023-10-26 |
The Research Foundation For The State University Of New York |
Asymmetric charged vesicles and methods of preparing and use thereof
|
US20230320993A1
(en)
|
2020-07-17 |
2023-10-12 |
Generation Bio Co. |
Methods for encapsulating polynucleotides into reduced sizes of lipid nanoparticles and novel formulation thereof
|
GB202011367D0
(en)
|
2020-07-22 |
2020-09-02 |
Micropore Tech Limited |
Method of preparing liposomes
|
US20230293434A1
(en)
|
2020-07-23 |
2023-09-21 |
The Regents Of The University Of California |
COMPOSITIONS COMPRISING miR-690 AND METHODS THEREFOR
|
KR20230087443A
(ko)
|
2020-08-06 |
2023-06-16 |
모더나티엑스, 인크. |
페이로드 분자를 기도 상피로 전달하기 위한 조성물
|
KR20230167008A
(ko)
|
2020-08-06 |
2023-12-07 |
모더나티엑스, 인크. |
지질 나노입자의 제조 방법
|
US20230338495A1
(en)
|
2020-08-19 |
2023-10-26 |
Vitruviae LLC |
Vaccine Compositions and Antibodies For Lyme Disease
|
EP4203987A2
(en)
|
2020-08-25 |
2023-07-05 |
The Regents of The University of California |
Compositions and methods for the treatment of ocular neuroinflammation
|
WO2022043551A2
(en)
|
2020-08-31 |
2022-03-03 |
Curevac Ag |
Multivalent nucleic acid based coronavirus vaccines
|
US20230310585A1
(en)
|
2020-09-11 |
2023-10-05 |
The University Of British Columbia |
Vaccine for viral pathogens
|